From the FDA:
The U.S. Food and Drug Administration today approved Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate), a new once-a-day combination pill to treat HIV-1 infection in adults who have never been treated for HIV infection.
Stribild contains two previously approved HIV drugs plus two new drugs, elvitegravir and cobicistat. Elvitegravir is an HIV integrase strand transfer inhibitor, a drug that interferes with one of the enzymes that HIV needs to multiply. Cobicistat, a pharmacokinetic enhancer, inhibits an enzyme that metabolizes certain HIV drugs and is used to prolong the effect of elvitegravir. The combination of emtricitabine and tenofovir disoproxil fumarate, approved in 2004 and marketed as Truvada, blocks the action of another enzyme that HIV needs to replicate in a person’s body. Together, these drugs provide a complete treatment regimen for HIV infection.
“Through continued research and drug development, treatment for those infected with HIV has evolved from multi-pill regimens to single-pill regimens,” said Edward Cox, M.D., M.P.H., director of the Office of Antimicrobial Products in FDA’s Center for Drug Evaluation and Research. “New combination HIV drugs like Stribild help simplify treatment regimens.”
Read the full FDA press release on the FDA Website.
In 2009 the Pitt Men’s Study celebrated its 25th anniversary. On that occasion, clinic coordinator Bill Buchanan gave a speech to volunteers and community representatives, the text of which is presented below.
In the early 1980s a new, puzzling, and deadly illness led a young gay doctor to approach a young straight microbiologist at Pitt and convince him that something needed to be done. They enlisted the help of the local gay establishment and started doing research without so much as a staff or a budget.
When the National Institutes of Health announced a grant for five research centers across the country, they applied, and soon Pittsburgh joined San Francisco, Los Angeles, Chicago, and Baltimore to form the Multicenter AIDS Cohort Study. The doctor and the microbiologist then hired a staff and enrolled over 1,000 men, many of whom are in this room. Continue reading
From the The Advocate:
The Centers for Disease Control has launched the largest survey ever conducted by a federal agency for gay and bisexual men in the United States at SexistheQuestion.org. According to HRC, Sex in the Question will also make a monetary donation to the It Gets Better Project for every survey complete.
The survey is aimed at understanding men’s sexual behaviors and health and finding ways to deal with STD and HIV transmission among men who have sex with men.
A quick online survey, Sex Is the Question is also one of the first surveys to provide immediate feedback based on participants answers so you know how you compare to other men who are taking the survey as well.
To take the survey and send money to It Gets Better, click here.